Dodatne informacije

• Lični podaci

• Datum rođenja: 30.12.1976.
• Mesto rođenja: Knjaževac, Srbija

• Obrazovanje

• Fakultet: Medicinski fakultet u Nišu
• Odsek / Grupa / Smer: medicina
• Godina diplomiranja: 2003.

• Spisak publikacija

• Monografije i poglavlja u monografijama:

  1. Lidija Kandolf, Suzana Matković, Milica Rajović, Dimitrije Brašanac, Vicko Ferenc, Snežana Bošnjak, Danica Grujičić, Rosanda Ilić, Ivana Milošević, Nenad Stepić, Željko Mijušković, Predrag Kovačević, Ljiljana Jauković, Srboljub Stošić, Ivan Marković, Jelena Jeremić, Danica Tiodorović, Borislava Nikolin, Dejan Rašić, Dušan Škiljević, Branislava Gajić, Radmila Janković, Jelena Nikolić, Mirjana Mijušković, Ivan Petković, Tatjana Arsenijević, Nenad Novaković, Mirjan Nadrljanski, Goran Stojković, Saša Milićević, Dejan Kostić, Marko Buta, Tatjana Roš, Milan Žegarac, Bojana Cikota Aleksić, Biljana Šeha, Zoran Andrić, Dejan Jovanović, Snežana Živković Perišić, Snežana Šušnjar, Marko Jevrić, Aleksandar Tomašević, Miroslav Tomić, Nada Santrač, Mihailo Milićević, Emina Milosavljević, Mirjana Balić, Jovica Glišić, Tamara Ursulović, Miodrag Jašović, Miona Stojanović, Kristina Juškić, Ćulibrk, Igor Đan, Nebojša Kozarević, Bojan Nikolić, Biljana Bubnjevac,Nenad Petrov. Nacionalni vodič: Melanom, prevencija, dijagnostika i lečenje. Ministarstvo Zdravlja Republike Srbije, Beograd 2024. Autor poglavlja: Drugi vidovi imunoterapije kod uznapredovalog melanoma. pp XX.   ISBN 978-86-6061-103-3 (AMNSLD)  (M41)

• Knjige i udžbenici:

  1. Stojanka Arsić, Olivera Žikić, Aleksandra Kostić, Biljana Kocić, Gordana Kostić, Danijela Radojković, Dragan Đorđević, Dragana Radović Janošević, Branka Mitić, Zorica Dimitrijević, Ranko Kutlešić, Predrag Vukomanović, Gordana Stanković Babić, Mila Bojanović, Ivan Petković, Olivera Radulović, Roberta Marković, Emina Kostić, Emilija Živković Marinkov. Uvod u kliničku praksu-komunikacija u medicini. Medicinski fakultet Niš 2022. Autor poglavlja: Komunikacija sa onkološkim pacijentom. pp 17-30. ISBN 978-86-6265-112-9  (M45)

  
  

   

• Radovi u časopisima sa IMPACT faktorom:

  1. Irena Conić, Bojan Nedović, Radomir Živadinović, R Živadinović, Aleksandra Petrić, Slavica Stojnev,  Ivan Petković, Dane Krtinić, Milica Radić. Analysis of progresion-free and overall survival in ovarian cancer: Bevacizumab treatment outcomes using hystorical cohort. Pharmazie 2024;79 (7):195-201.  doi: 10.1691/ph.2024.4570  PMID: 39407422 IF₍₂₀₂₃₎:1.5 (M23) 5-IF₍₂₀₂₃₎: 1.4

  
  

  2. Dane Krtinic, Gorana Nedin Rankovic,  Ivan Petković, Ana Cvetanovic, Irena Conic, Mirjana Todorovic Mitic, Milica Radic, Milan Cevrljakovic, Suzana Tosic Golubovic, Iva Binic, Marija Andjelkovic Apostolovic, Hristina Jovanovic, Hristina Trajkovic, Dragana Milijasevic, Nevena Mladenovic, Rada Lukic. DN4 questionnaire as a useful tool for evaluating the pharmacotherapeutic response to opioid pharmacotherapy in malignant neuropathy. Pharmazie 2024;79 (6):109-113. doi:10.1691/ph.2024.4513  PMID: 38877683 IF₍₂₀₂₃₎: 1.5  (M23) 5-IF₍₂₀₂₃₎: 1.4

  
  

  3. Slavica Stojnev, Irena Conic, Ana Ristic Petrovic, Ivan Petkovic, Milica Radic, Miljan Krstic, Ljubinka Jankovic Velickovic. The association of death receptors and TGF-β1 expression in urothelial bladder cancer and their prognostic significance. Biomedicines 2024;12(5):1123. doi: 10.3390/biomedicines12051123 PMID: 38791085 IF (2023):3.9 (M22) 5-IF ₍₂₀₂₃₎: 4.1

  
  

  4. Dane Krtinić, Gorana Nedin Ranković, Ivan Petković, Ana Cvetanović, Irena Conić, Mirjana Todorović Mitić, Milica Radić, Boris Milisavljević, Aleksandra Lučić Prokin, Vladimir Đorđević, Hristina Jovanović, Hristina Trajković, Marija Anđelković, Dragana Milijašević, Ranko Zdravković, Iva Binić. The role of tapentadol in the cancer pain pharmacotherapy in patients with metastatic malignant disease. Eur Rev Med Pharmacol Sci 2023; 27 (24): 12112-12120.  doi:  10.26355/eurrev_202312_34809    PMID: 38164873  IF(2022): 3.3 (M22) 5-IF₍₂₀₂₂₎: 3.1

  
  

  5. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Andrija Jović. Prognostic value of lactate dehydrogenase in melanoma patients treated with pembrolizumab. Acta Dermatovener Cr 2023; 31 (2): 86-91.   PMID:38006368 IF₍₂₀₂₃₎: 0.6 (M23) 5-IF₍₂₀₂₃₎: 1.1

  
  

  6. Vanja Đurić, Bojana Stamenković,  Ivan Petković, Luka Đurić. Prevalence of various forms of peripheral neuropathy in patients with systemic connective tissue diseases: a clinical and electrophysiological study. Vojnosanit Pregl 2023; 80 (7): 561-9. doi: 10.2298/VSP211005090D  PMID: suppresed  IF(2023): 0.2 (M23) 5-IF₍₂₀₂₃₎: 0.2

  
  

  7. Miljana Džunić,  Ana Cvetanović, Ivan Petković, Ivana Todorović Stojanović. Pathologic complete response in metastatic right-sided colon cancer treated with panitumumab and FOLFOX4 chemotherapy regimen. Srpski Arhiv 2022; 150 (11-12):716-20. doi:10.2298/SARH220419082D   IF₂₀₂₂: 0.2 (M23) 5-IF₂₀₂₂: 0.2

  
  

  8. Miljan Krstic, Slavica Stojnev, Ivan Petkovic, Irena Conic, Janko Zujovic, Velimir Milosevic. Pathomorphological and clinical features of diffuse large B-cell lymphoma in Southeastern Serbia – seven-year experience at a tertiary center. J BUON 2021; 26 (6): 2536-43. PMID: suppresed   IF₂₀₂₀: 2.533 (M23) 5-IF₂₀₂₀: 1.987

  
  

  9. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. EBV negative angioimmunoblastic T–cell lymphoma with sequential development of diffuse large B–cell lymphoma in course of progression. Indian J Hematol Blood Transfus  2021; 37 (4): 694-6.    doi: 10.1007/s12288-021-01425-w PMID: 34744354 IF2021: 0.915 (M23)  5-IF₂₀₂₁ : 1.003

  
  

  10. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. Extranodal NK/T–cell lymphoma, nasal type overlapping aggressive NK–cell leukemia in course of progression. UHOD-Uluslar Hematol 2020; 30 (4): 248-51.    doi:10.4999/uhod.204767   IF₂₀₂₀: 0.200       (M23)             5-IF 2020: 0.230
  

  
  

  11. Miljana Dzunic, Marija Andjelkovic-Apostolovic, Svetislav Vrbic, Ivica Pejcic, Ivan Petkovic, Ana Cvetanovic, Sasa Dinic. Survival of patients with liver metastases from colorectal cancer treated with bevacizumab and FOLFOX4. J BUON 2020; 25 (1): 212-9.  PMID: 32277634   IF (2020): 2.533 (M23) 5-IF₂₀₂₀: 1.987

  
  

  12. Miljana Dzunic, Ivan Petkovic, Ana Cvetanovic, Svetislav Vrbic, Ivica Pejcic. Current and future targets and therapies in metastatic colorectal cancer - Status Change. J BUON 2019; 24 (5): 1785-92.  PMID: 31786838  IF ₂₀₁₉: 1.695 (M23) 5-IF 2019: 1.453

  
  

  13. Slavica Stojnev, Miljan Krstić, Jovana Čukuranović Kokoris, Irena Conić, Ivan Petković, Sonja Ilić, Jelena Milošević Stevanović, Ljubinka Janković Veličković. Prognostic impact of canonical TGF-β signaling in urothelial bladder cancer. Medicina (Kaunas) 2019;55 (6): 302. doi:10.3390/medicina55060302  PMID: 31238579   IF ₍₂₀₁₉₎: 1.205       (M23)  5-IF 2019: 1.572

  
  

  14. Darko Antic, Jelena Jelicic, Goran Trajkovic, Milena Todorovic Balint, Jelena Bila, Olivera Markovic, Ivan Petkovic, Vesna Nikolic, Bosko Andjelic, Vladislava Djurasinovic, Aleksandra Sretenovic, Mihailo Smiljanic, Vojin Vukovic, Biljana Mihaljevic. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B-cell lymphoma?  The prognostic significance of comorbidities. Ann Hematol 2018; 97 (2): 267-76.  doi: 10.1007/s00277-017-3170 z PMID: 29130134 IF ₂₀₁₈: 2.850   (M22) 5-IF 2018: 2.811

  
  

  15. Olivera Simonović, Milena Todorović, Biljana Mihaljević, Tatjana Stoimenov-Jevtović, Ivan Petković, Lana Mačukanović-Golubović, Goran Marjanović. Serum biomarkers and clinical characteristics of patients with classical Hodgkin lymphoma. Vojnosanit Pregl 2018; 75 (9): 911-917. doi: 10.2298/VSP160705018S     PMID: awaiting IF 2018: 0.272 (M23)  5-IF 2018: 0.418

  
  

  16. Slavica Stojnev, Miljan Krstić, Ivan Ilić, Ivan Petković, Simonida Stojanović, Predrag Cvetković, Pavle Randjelović, Ljubinka Veličković. Acute myocardial infarction with Trousseau’s syndrome: case report and review of the literature. W Indian Med J 2017; u štampi  doi:10.7727/wimj.2016.140 https://www.mona.uwi.edu/fms/wimj/article/2982# PMID: awaiting  IF ₂₀₁₆: 0.224  (M23) 5-IF 2016 0.3

  
  

  17. Ivan Petković, Ivica Pejčić, Danica Tiodorović, Miljan Krstić, Slavica Stojnev, Svetislav Vrbić. Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type. Postepy Dermatol Alergol 2017; 34 (6): 625-8.         doi:10.5114/pdia.2017.66625  PMID: 29422831 IF ₂₀₁₇: 1.471   (M23) 5-IF 2017: 1.407

  
  

  18. Biljana Mihaljevic, Jelena Jelicic, Boško Andjelic, Darko Antic, Olivera Markovic, Ivan Petkovic, Maja Perunicic Jovanovic, Goran Trajkovic, Jelena Bila, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihailo Smiljanic, Milena Todorovic Balint. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma. Int J Hematol 2016; 104 (6): 692–9. doi: 10.1007/s12185-016-2099-7 PMID: 27714586 IF ₂₀₁₆: 1.610  (M23)  5-IF 2016: 1.621

  
  

  19. Ivan Petković, Slavica Stojnev, Miljan Krstić, Ivica Pejčić, Svetislav Vrbić. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence? Vojnosanit Pregl 2016; 73 (11): 1072-75. doi: 10.2298/VSP150425125P     PMID: 29341562  IF ₂₀₁₆: 0.367 (M23) 5-IF 2016: 0.382

  
  

  20. Ivan Petković. Current trends in the treatment of primary mediastinal large B-cell lymphoma-an overview. Contemp Oncol (Pozn) 2015; 19 (6): 428-35.  doi:10.5114/wo.2015.56388  PMID: 26843837  5-IF: 0.150 (M23) 

  
  

  21. Ivan Petkovic. Follicular lymphoma-reply. Turk J Hematol 2015; 32 (1): 95.  doi: 10.4274/tjh.2014.0380 PMID: 25805689  IF ₂₀₁₅: 0.827   (M26) 5-IF2015: 0.579
  

  
  

  22. Ivan Petković, Ivica Pejčić, Svetislav Vrbić. Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma? Contemp Oncol (Pozn) 2014; 18 (6): 377-83.    doi: 10.5114/wo.2014.45111 PMID: 25784834      5-IF: 0.150  (M23)

  
  

  23. Ivan Petković, Miljan Krstić, Ivica Pejcić, Svetislav Vrbić, Slavica Stojnev, Ana Cvetanović, Mirjana Balić, Mirjana Todorović. Renal infiltration of Follicular Lymphoma. Turk J Hematol 2014; 31 (3): 315-6.   doi: 10.4274/tjh.2014.0013 PMID: 25330530  IF ₂₀₁₄: 0.360 (M23) 5-IF 2014: 0.359

  
  

  24. Ivica Pejcic, Ivan Petkovic, Svetislav  Vrbic, Sladjana Filipovic, Mirjana Balic, Ana Cvetanovic. Mantle cell lymphoma-current literature overview. J BUON 2014; 19 (2): 342-9.  PMID: 24965390  IF ₂₀₁₄: 0.761  (M23) 5-IF 2014: 0.686

  
  

  25.  Ana Cvetanovic, Svetislav Vrbic, Sladjana Filipovic, Ivica Pejcic, Dusan Milenkovic, Nikola Zivkovic, Milos Kostic, Ivan Petkovic. Clinical benefit of Cetuximab and prognostic values of Cetuximab-related skin toxicity in metastatic colorectal cancer: a single institution analysis. J BUON 2014; 19 (1): 83-90.    PMID: 24659647  IF ₂₀₁₄: 0.761  (M23) 5-IF 2014: 0.686

  
  

  26.  Ivica Pejcic, Svetislav Vrbic, Sladjana Filipovic, Mirjana Scekic, Ivan Petkovic, Ljiljana Pejcic. Concurrent chemoimmunotherapy: is it still the best option for the treatment of metastatic melanoma in patients with good performance status? J BUON 2010; 15 (3): 470-4.      PMID: 20954411         IF ₂₀₁₀: 0.482   (M23) 5-IF 2010: 0.6

  
  

  27.  Ivica Pejčić, Svetislav Vrbić, Slađana Filipović, Mirjana Šćekić, Ivan Petković, Ljiljana Pejčić, Nebojša Đenić. Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site. Vojnosanit Pregl 2010; 67 (9): 723-31.         doi: 10.2298/VSP1009723P        PMID: 20954411    IF ₂₀₁₀: 0.199    (M23) 5-IF 2010: 0.2

  
  

   

  
  

   

  
  

   

• Radovi u ostalim časopisima:

  1. Ivan Petković, Marija Elez, Aleksandar Popović, Slavica Stojnev, Irena Conić, Miljana Džunić, Dane Krtinić. Polatuzumab-Vedotin+Bendamustin+Rituximab as a salvage and bridging therapy in relapsed/refractory diffuse large B-cell lymphoma-case presentation and literature overview. Acta Fac Med Naiss 2025; 42 (x): xx-xx.  doi: 10.5937/afmnaixx-xxxxx  IF₍₂₀₂₃₎:0.3     (M51) 

  
  

  2. Aleksandar Popović, Ana Stojković, Ana . Cvetanović,  Andrija Jović, Irena Conicć, Milica Radić, Ivan Petković. Vitiligo like depigmentation as a predictor of long term response on immune check point inhibitors in patients with an advanced melanoma: a single center experience. Acta Fac Med Naiss 2024; 41 (4): xx-xx. doi: 10.5937/afmnai40-40566        IF₂₀₂₃:0.3   (M51)

  
  

  3. Milica Radić, Aleksandar Popović, Katarina Krasić, Andrija Jović, Irena Conić, Ana Cvetanović, Ivan Petković. Postoperative three-dimensional conformal radiotherapy in the patient with a significant cardiovascular risk – case report. Acta Medica Medianae 2024; 63 (x): xx-x.     doi: 10.5633/amm.2024.0411   (M52)

  
  

  4. Dylan Alford, Ivan Petković. Prognostic Significance of BCL-2 Expression in Non-GCB Diffuse Large B-Cell Lymphoma. Cureus 2024;16(6):e62031.  doi:10.7759/cureus.62031  PMID:38989351  IF₍₂₀₂₃₎:1.0  (M51)

  
  

  5. Aleksandar Popović, Ivan Petković, Andrija Rančić, Aleksandra Dimitrijević, Vesna Brzački, Andrija Jović, Stefan Stankov, Sonja Stojanović. Nivolumab in patient with mucosal melanoma and systemic lupus-case report and  a literature review. Acta Fac Med Naiss 2023; 40 (4): 505-11.   doi:  10.5937/afmnai40-40566  IF₍₂₀₂₃₎:0.3  (M51)

  
  

  6. Miljana Džunić, Ana Cvetanović, Ivan Petković. Perimandibular metastasis of rectal cancer: a case report. Acta Fac Med Naiss 2023; 40 (3): 352-7.   doi: 10.5937/afmnai40-38706   IF₍₂₀₂₃₎:0.3 (M51)         

  
  

  7. Ivan Petković. Chemotherapy induced assymmetrical melanonychia. Acta Fac Med Naiss 2022; 39 (3): 380-4. doi: 10.5937/afmnai39-36282  IF₂₀₂₂:0.2 (M51)

  
  

  8. Miljan Krstić,  Slavica Stojnev, Ivan Petković. Mantle cell lymphoma- a killer with a face of a child. Acta Medica Medianae 2022; 61 (1): 23-9.  doi: 10.5633/amm.2022.0103   (M52)

  
  

  9. Miljana Džunić, Ivan Petković, Ana Cvetanović, Ivica Pejčić, Svetislav Vrbić, Saša Dinić. Prognostic parameters in patients with resected liver metastases from colorectal cancer after biological and chemotherapy. Acta Fac Med Naiss 2020; 37 (4): 349-58.   doi: 10.5937/afmnai2004349D    (M51)

  
  

  10. Ivan Petković, Aleksandar Popović, Miljana Džunić, Ivica Pejčić. Nodal and extranodal peripheral T/NK-cell neoplasms: current aspects. Acta Fac Med Naiss 2020; 37 (2): 99-120.  doi: 10.5937/afmnai37-24708    (M51)

  
  

  11. Miljana Džunić, Bojana Pejčić, Marija Anđelković-Apostolović, Svetislav Vrbić, Ivica Pejčić, Ivan Petković. Predictors of therapy response and early reccurence in patients with potentially resectabile colorectal liver metastases treated with bevacizumab and FOLFOX4 as a conversion therapy. Acta Medica Medianae 2019; 58 (3): 72-9.      doi: 10.5633/amm.2019.0310  (M51) 

  
  

  12. Mladen Đorđević, Ivan Petković. Dichlor-acetate induced polyneuropathy in high grade follicular lymphoma patient. Acta Medica Medianae 2019;  58 (1): 102-5.  doi: 10.5633/amm.2019.0114    (M51)

  
  

  13. Ivica Pejčić, Ivan Petković, Ana Cvetanović, Irena Conić. Single center experience study with Pembrolizumab in patients with BRAF mutant negative metastatic melanoma. Acta Fac Med Naiss 2018; 35 (4): 267-72.  doi: 10.2478/afmnai-2018-0028    (M51)

  
  

  14. Slavica Stojnev, Ana Ristić, Miljan Krstić, Ana Ristić-Petrović, Irena Conić, Ivan Petković, Jelena Milenković, Ljubinka Janković-Veličković. Expression of epigenetic silencer EZH2 in early invasive pT1 urothelial bladder cancer. Acta Medica Medianae 2018; 57 (3): 48-54.  doi: 10.5633/amm.2018. 0306   (M51)

  
  

  15. Novica Dimić, Dragan Krasić, Bojana Stamenković, Marina Vlajković, Ivan Petković, Dragan Dimić, Miljan Krstić, Nikola Živković, Dušanka Marković. MALT lymphoma in primary Sjogren’s syndrome patient-a case report. Balneoclimatologia 2018; 42 (1): 229-39.  (M53)

  
  

  16. Jovan Nikolić, Aleksandra Milićević, Jadranka Paravina, Ivan Petković, Milica Mihailović, Miloš Stanković, Žaklina Mijović, Dragan Mihailović. Histopathologic and clinical features of rapidly progressive ALK-negative cutaneous anaplastic large T-cell lymphoma. Acta Medica Medianae 2017; 56 (3): 55-61.  doi: 10.5633/amm.2017.0309   (M51)

  
  

  17. Miodrag Vrbić, Ivan Petković, Svetislav Vrbić, Maja Jovanović, Aleksandar Ranković, Lidija  Popović-Dragonjić, Marina Djordjević-Spasić. Two-Year Complete Remission of Diffuse Large B-cell Lymphoma in an Immunological Nonresponder HIV -infected Patient: Case Report. Case Rep Oncol 2017; 10 (1): 356-360.     doi: 10.1159/0004718472  PMID: 28559819  (M51)

  
  

  18. Ivan Petković,  Ivica Pejčić, Svetislav Vrbić. Proteazomni inhibitori-racionala kliničke primene u tretmanu multiplog mijeloma. Racionalna Terapija 2016; 8 (2): 25-33.  doi: 10.5937/racter8-10447  (M52)

  
  

  19. Ivan Petković, Miljan Krstić, Slavica Stojnev, Ivica Pejčić, Svetislav Vrbić. Extensive bone marrow involvement in Hodgkin lymphoma patient. Acta Fac Med Naiss 2014; 31 (4): 261-5.                                    doi: 10.2478/afmnai-2014-0032   (M52)    

  
  

  20. Ivica Pejčić, Svetislav Vrbić, Mirjana Todorović, Ivan Petković, Mirjana Balić, Ana Stanković. Cancer of unknown primary site syndrome-CUP syndrome-diagnostic and therapeutic dillemas. Acta Fac Med Naiss 2014; 31 (2): 87-94.  doi: 10.2478/afmnai-2014-0010    (M52)

  
  

  21. Ivan Petković, Ivica Pejčić, Svetislav Vrbić. New frontiers of target therapy in oncology: acute promyelocytic leukemia. Acta Fac Med Naiss 2014; 31 (1): 17-28.   doi: 10.2478/afmnai-2014-0002  (M52) 

  
  

  22. Ivan Petković, Dragan Mihailović, Miljan Krstić, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Burkitt lymphoma in elderly patients – a case report. Acta Fac Med Naiss 2013; 30 (2): 103-9.                        doi: 10.2478/v10283-012-0044-0   (M52)

  
  

  23. Ivan Petković, Dragan Mihailović, Miljan Krstić, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Primary mantle cell lymphoma of gastrointestinal tract - a case report. Acta Medica Medianae 2012; 51 (3): 41-6.  doi: 10.5633/amm.2012.0307 (M52)

• Radovi na naučnim skupovima međunarodnog značaja:

  1. Aleksandar Popović, Branko Dujović, Ana Stojković, Ivana Jocić, Amina Jalovčić Suljević, Emir Sokolović, Ivan Petković, Lidija Kandolf. Predictive value of inflammatory ratios on the outcome of advanced melanoma patients treated with anti-PD1 monotherapy: a multicentric analysis [Meeting Abstract]. IOTECH 2024; Volume 24, Supp,100824. doi:10.1016/j.iotech.2024.100824           ESMO Immuno-Oncology Congress 2024, Geneve, Switzerland  (M34)

  
  

  2. Ivan Petković, Aleksandar Popović, Ana Stojković, Slavica Stojnev, Irena Conić, Dane Krtinić. Clinical characteristics of multiple lymphomatous polyposys – digestive form of mantle cell lymphoma-single experience of the oncology clinic UCC Niš [Meeting Abstract]. Abstract book pp 06, 23-5.  1. Kongres hematologa Crne Gore sa međunarodnim učešćem, 12-15.sept 2024 Budva, CG  (M34)

  
  

  3. Ivan Petković, Aleksandar Popović, Ana Stojković, Slavica Stojnev, Irena Conić, Dane Krtinić. Clinical characteristics and treatment outcomes of patients with relaps/refractory mantle cell lymphoma treated with ibrutinib- single center experience of the Oncology clinic University Clinical Center Nis [Meeting Abstract]. Abstract book pp 07, 23-5.             1. Kongres hematologa Crne Gore sa međunarodnim učešćem, 12-15.sept 2024 Budva, CG   (M34)

  
  

  4. Ivan Petković, Sheeren Rahmani, Aleksandar Popović, Slavica Stojnev. Prognostic significance of bcl-2 protein expression in GCB subtype of Diffuse B large cell lymphoma [Meeting Abstract]. Abstract book pp 05, 23-5.   1. Kongres hematologa Crne Gore sa međunarodnim učešćem, 12-15.sept 2024 Budva, CG  (M34)

  
  

  5. Aleksandar Popović, Ana Stojković, Ivan Petković, Andrija Jović, Mirjana Balić, Ana Cvetanović. Vitiligo like depigmentation as a predictor of prolonged response to immune checkpoint inhibitors in patients with advanced melanoma - single center experience [Meeting Abstract]. Abstract book Id1543.  European Academy of Dermatology and Venerology Congress 25-28. Sept 2024 Amsterdam, Netherlands (M34)

  
  

  6. Krtinic Dane, Nedin Rankovic Gorana, Petkovic Ivan, Cvetanovic Ana, Conic Irena, Lucic Prokin Ana, Todorovic Mitic Mirjana, Radic Milica, Jovanovic Hristina, Trajkovic Hristina, Cevrljakovic Milan, Pejcic Vanja, Cekic M. Karnofsky index as a predictive factor in the pharmacotherapy of bone metastases cancer pain [Meeting Abstract]. Abstract book PP270. EPHAR2024 9^th European Congress of Pharmacology, 23-26.6.2024 Athens, Greece  (M34)

  
  

  7. Slavica Stojnev, Miljan Krstic, Ana Ristic Petrovic, Irena Conic, Ivan Petkovic,  J Todorovic, M Mladenovic, Ljubinka Jankovic Velickovic. Prognostic significance of death receptors expression in primary and recurrent T1 bladder cancer [Meeting Abstract]. Virchows Archiv 2023; 483 (1) (Suppl 1): S143. PS-26-024  35th European Congress of Pathology 2023  Dublin, Ireland (M34)

  
  

  8. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Lidija Kandolf, Branko Dujović, Ivana Jocić, Marina Petronijević, Andrija Jović, MIrjana Todorović Mitić, MIrjana Balić, Philipp Schnecks. Response to anti-PD1 treatment in acral melanoma [Meeting Abstract]. Abstract book Id27. 19^th EADO Congress 20-22. April 2023 Rome, Italia (M34)

  
  

  9. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Lidija Kandolf, Branko Dujović, Ivana Jocić, Marina Petronijević, Andrija Jović, MIrjana Todorović Mitić, MIrjana Balić, Philipp Schnecks. Response to anti-PD1 treatment in cutaneous head and neck melanoma [Meeting Abstract]. Abstract book Id27.   19^th EADO Congress 20-22. April 2023 Rome, Italia (M34)

  
  

  10. Aleksandar Popović, Ivan Petković, Dimitrijević Aleksandra, Balić Mirjana, Jović Andrija, Dujović Branko, Lidija Kandolf Sekulović, Ivica Pejčić. Prognostic Value of Lactate Dehydrogenase in Melanoma Patients Treated With Pembrolizumab [Meeting Abstract]. Abstract book p Id26.  18^th EADO Congress 21-23. April 2022. Sevilla, Espana  (M34)

  
  

  11. Aleksandar Popović, Ivan Petković, Balić Mirjana, Dimitrijević Aleksandra, Tiodorović Danica, Spasić D, Stevanović Goran, Jović Andrija, Ivica Pejčić. Single Center Experience with Pembrolizumab in Therapy Naive Advanced Melanoma Patients [Meeting Abstract]. Abstract book p Id27. 18^th EADO Congress 21-23. April 2022. Sevilla, Espana  (M34)

  
  

  12. Slavica Stojnev, Miljan Krstic, Ana Ristic, Ivan Petkovic, Irena Conic, Ana Ristic Petrovic, J Todorovic, M Mladenovic. Association of STAT3 expression and enhanced angiogenesis in primary extranodal diffuse large B cell lymphoma [Meeting Abstract]. Virchows Archiv 2021; 479 (1) (Suppl 1): S116. PS-10-008  33^rd European Congress of Pathology 2021 Gothenburg, Sweden (M34)

  
  

  13. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Stefan Stankov, Ivica Pejčić, Svetislav Vrbić. Single center experience study with pembrolizumab in patients with unresectable and metastatic melanoma [Meeting Abstract]. Libri Oncologici 2021; 49 (suppl 2): 67. 3^rd Rekonio Conference-Regional Balcan Oncology Meeting 2021  (M34)

  
  

  14. Aleksandar Popović, Branko Dujović, Ivan Petković, Danica Tiodorović, Lidija Kandolf Sekulović, Aleksandra Dimitrijević, Andrija Jović, Ivica Pejčić. Significance of body mass index on the efficacy and safety profile of pembrolizumab in melanoma patients [Meeting Abstract]. Abstract book p 168, 204.  10th World  Congress of Melanoma in conjuction with 17th EADO, 15-17. april 2021.  (M34)

  
  

  15. Miljan Krstic, Maja Perunicic Jovanovic, Slavica Stojnev, Petar Jovanovic  Ivan Petkovic, Darko Antic. Clinicopathologic analysis of splenic lymphoma: three year experinece [Meeting Abstract]. Abstract book pp 64, 134-5.  EAHP 19th Meeting of the European Association for Haematopathology, Edinburgh, Scotland, United Kingdom 2018  (M34)

  
  

  16. Jelena Jelicic, Darko Antic, Milena Todorovic Balint, Bosko Andjelic, Olivera Markovic,  Ivan Petkovic, Vesna Nikolic, Jelena Bila, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihailo Smiljanic, Snezana Sretenovic, Biljana Mihaljevic. High comorbidity index along with high NCCN-IPI strongly influence survival of diffuse large B cell lymphoma patients: Serbian Lymphoma Group experience  [Meeting Abstract]. Haematologica 2017; 102 (Suppl 2): 399.   (M34) 

  
  

  17.  Jelena Jelicic, Darko Antic, Milena Todorovic Balint, Bosko Andjelic, Olivera Markovic,  Ivan Petkovic, Vesna Nikolic, Jelena Bila, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihailo Smiljanic, Snezana Sretenovic, Biljana Mihaljevic. Low albumin level correlates with poorer survival of patients with diffuse large B cell lymphoma: Serbian Lymphoma Group experience [Meeting Abstract]. Haematologica 2017; 102 (Suppl 2): 688.   (M34) 

  
  

  18. Miljan Krstic, Slavica Stojnev, Ivan Petkovic. STAT3 expression in diffuse large B–cell lymphoma of nodal and extranodal localization [Meeting Abstract]. Abstract book pp 75, 145-6.  EAHP 18^th Meeting of the European Association for Haematopathology, Basel, Switzerland 2016 (M34)

  
  

  19. Jelena Jelicic, Milena Todorovic, Bosko Andjelic, Darko Antic, Olivera Markovic,  Ivan Petkovic, Aleksandra Sretenovic, Jelena Bila, Vojin Vukovic, Vladislava Djurasinovic, Mihailo Smiljanic, Ivica Pejicic, Biljana Mihaljevic. The absolute lymphocyte count as independent pararmeter may predict prognosis of follicular lymphoma patients [Meeting Abstract]. Haematologica 2016; 101 (Suppl 1): 753.   (M34) 

  
  

  20. Jelena Jelicic, Milena Todorovic Balint, Darko Antic, Bosko Andjelic, Olivera Markovic, Ivan Petkovic, Aleksandra Sretenovic, Jelena Bila, Vojin Vukovic, Vladislava Djurasinovic, Mihailo Smiljanic, Ivica Pejicic, Biljana Mihaljevic. Analysis of clinical parameters, absolute lymphocyte count in patients with diffuse large B cell lymphoma [Meeting Abstract]. Haematologica 2016; 101 (Suppl 1): 706.  (M34)  

  
  

  21. Jelena Jelicic, Milena Todorovic, Darko Antic, Jelena Bila, Bosko Andjelic, Dejana Stanisavljevic, Vladislava Djurasinovic, Aleksandra Sretenovic, Vojin Vukovic, Mihajlo Smiljanic, Ivan Petkovic, Ivica Vrbic, Biljana Mihaljevic. The role of prognostic and comorbidity indexes in patients with diffuse large B cell lymphoma treated with immunochemotherapy [Meeting Abstract]. Haematologica 2015; 100 (Suppl 1): 660-1.  (M34) 

  
  

  22. Vesna Nikolić, Darko Antić, Boško Andjelić, Milena Todorović, Tomislav Vukićević, Ivica Pejčić, Ivan Petković, Stevan Popović, Lazar Popović, Nebojša Andjelković, Snežana Sretenović, Olivera Marković, Jelena Knežević, Biljana Mihaljević. Prognostički značaj Ki-67 indeksa u bolesnika sa difuznim krupnoćelijskim B-limfomom koji su lečeni Rituximabom plus CHOP-iskustva Srpske limfomske grupe [Meeting Abstract]. 2. Kongres hematologa Srbije/6th Balkan Day Haematology, Belgrade 2011. Abstract book pp 08, 23-5. (M34)

  
  

  23. Mihaljević Biljana, Antić Darko, Anđelić Boško, Todorović Milena, Vukićević Tomislav, Nikolić Vesna, Pejčić Ivica, Petković Ivan, Popović Lazar, Anđelković Nebojša, Sretenović Snežana, Smiljanić Mihailo, Marković Olivera. Prognostic significance of the Ki-67 index in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP-experience of Serbian Lymphoma Study Group [Meeting Abstract]. Haematologica 2011; 96 (Suppl 2): 575-6.  (M34)

  
  

  24. Mihaljević Biljana, Antić Darko, Anđelić Boško, Vukićević Tomislav, Nikolić Vesna, Pejčić Ivica, Petković Ivan, Popović Stevan, Popović Lazar, Anđelković Nebojša, Sretenović Snežana, Leković Danijela, Smiljanić Mihailo, Marković Olivera, Knežević V, Kecman Vladimir. Characteristics of 917 Non-Hodgkin Lymphoma Patients in Serbia According to the WHO Classification of Lymphoid Neoplasms-Lira National Register-Based Study [Meeting Abstract].  Ann Oncol 2011; 22 (4): 204.  (M34)

  
  

  25. Mihaljević Biljana, Anđelić Boško, Antić Darko, Todorović Milena, Vukićević Tomislav, Nikolić Vesna, Pejčić Ivica, Petković Ivan, Popović Stevan, Savić Ivanka, Popović Lazar, Anđelković Nebojša, Sretenović Snežana, Knežević Jelena, Kecman Vladimir. Diffuse Large B-cell Lymphoma: Germinal Center Vs Non Germinal Center - Treatment Response on Immunochemotherapy. Serbian Lymphoma Study Group [Meeting Abstract]. Ann Oncol 2011; 22 (4): 224-5.   (M34)

  
  

   

  
  

   

• Radovi na domaćim naučnim skupovima:

  1. Ivan Petković. Mantle cell lymphoma-current aspects. Abstract Book pp, xx-xx.  61. Kancerološka nedelja, Beograd 2024.  (M62)

  
  

  2. Ivan Petković. Follicular lymphoma-current aspects. Abstract Book pp, xx-xx.  61. Kancerološka nedelja, Beograd 2024.  (M62)

  
  

  3. Aleksandar Popović, Branko Dujović, Ivana Jocić, Ana Stojković, Marina Petronijević, Nemanja Kolović, Ivan Petković, Mirjana Balić, Suzana Matković, Borislava Nikolin, Tatjana Radević, Željko Mijušković, Jovica Glišić, Emina Milosavljević, Lidija Kandolf. First line anti PD1 vs. Combined target therapy in patients with BRAF mutant advnaced melanoma: results from tertiary centers from Serbia. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  4. Ana Stojković, Aleksandar Popović, Ivan Petković, Ana Cvetanović, Kristina Janković, Lazar Stošić. Procena odnosa neutrofila i limfocita kod pacijenata sa Hodgkinovim limfomom (HL): iskustvo Klinike za onkologiju UKC Niš. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  5. Ana Stojković, Aleksandar Popović, Ivan Petković, Ana Cvetanović, Ana Petrović, Kristina Janković. Kompletan odgovor na terapiju Polatuzumab-vedotin+Rituximab+Bendamustin u relaps/refraktarnom difuznom B krupnoćelijskom limfomu želuca (R/R PG-DBKL)- prikaz slučaja. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  6. Ana Stojković, Aleksandar Popović, Ivan Petković, Mirjana Balić, Ana Cvetanović. Pembrolizumabom indukovan dijabetes melitus tip 1 kod pacijentkinje sa metastatskim melanomom-prikaz slučaja. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  7. Ana Stojković, Ivan Petković, Aleksandar Popović, Kristina Janković, Miljana Džunić, Jelena Krstić, Ana Cvetanović. Ozbiljna dermatološka toksičnost povezana sa primenom imatinib mesilata u tretmanu metastatskog gastrointestinalnog stromalnog tumora (GIST) ileuma: prikaz slučaja. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  8. Irena Conić, Slavica Stojnev, Ivan Petković, Ana Cvetanović, Dane Krtinić, Milica Radić, Marijana Milović Kovačević. Serozni adenokarcinom jajnika niskog gradusa sa metastatskim depozitima u regiji vrata i aksili.  Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  9. Ana Petrović, Aleksandar Popović, Ivan Petković, Ana Stojković, Mirjana Balić, Ana Cvetanović. Pembrolizumab kao most ka autolognoj transplantaciji matičnih ćelija kod pacijenata sa refraktarnim Hodgkinovim limfomom. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  10. Milan Čevrljaković, Vesna Stojanović, Aleksandra Dimitrijević, Kristina Janković, Ivan Petković, Ana Cvetanović. Dugotrajan terapijski odgovor nakon primene avelumaba kod pacijenta sa urotelijalnim karcinomom: prikaz slučaja. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  11. Milan Čevrljaković, Vesna Stojanović, Aleksandra Dimitrijević, Mirjana Todorović Mitić, Dane Krtinić, Kristina Janković, Ivan Petković, Ana Cvetanović. Primena anti-PD-L1 inhibitora, avelumaba, kod pacijenata sa uznapredovalim i metastatskim urotelijalnim karcinomom – iskustvo klinike za onkologiju UKC Niš. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  12. Kristina Janković, Ana Cvetanović, Lazar Stošić, Milan Čevrljaković, Ana Stojković, Marija Jevtić, Ivan Petković. Karcinom dojke kod muškaraca: iskustvo Klinike za onkologije UKC Niš. Abstract Book pp, xx-xx.  61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  13. Kristina Janković, Ana Cvetanović, Milan Čevrljaković, Ana Stojković, Ivan Petković, Irena Conić. Imunoterapija u lečenju ranog trostruko negativnog carcinoma dojke-prikaz slučaja. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  14. Jovana Mitrovski, Mirjana Todorović Mitić, Jelena Pavlović, Maja Milivojević, Ana Cvetanović, Ivan Petković. Prikaz pacijenta sa kožnim melanomom u trećem kliničkom stadijumu lečenog adjuvantnom terapijom pembrolizumabom – trogodišnje praćenje. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  15. Maja Milivojević, Miljana Džunić, Marija Jevtić, Jelena Pavlović, Jovana  Mitrovski, Dragana Ševo, Ivan Petković, Ana Cvetanović. Kožne metastaze karcinoma rektuma: prikaz slučaja. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024. (M64)

  
  

  16. Jelena Krstić, Miljana Džunić, Milan Čevrljaković, Marija Jevtić, Dušan Radomirović, Ana Stojković, Ivan Petković, Ana Cvetanović. Durvalumab u kombinaciji sa gemcitabinom i cisplatinom u lečenju metastatskog holangiocelularnog karcinoma: prikaz slučaja. Abstract Book pp, xx-xx. 61. Kancerološka nedelja, Beograd 2024.   (M64) 

  
  

  17. Ivana Mitić, Irena Conić, Ana Cvetanović, Ilinka Todorovska, Ivan Petković. Case report of a patient with duplex carcinoma of the breast and ovary. Abstract Book pp,xx-xx. 61. Kancerološka nedelja, Beograd 2024. 

  
  

  18. Ivan Petković, Dylan Alford, Aleksandar Popović, Slavica Stojnev. Prognostic significance of bcl-2 expression in non-germinal center B-cell-like diffuse large B-cell lymphoma (DLBCL). Srpski Medicinski Časopis Lekarske Komore 2024; 5 (suppl 3):55.   6. Kongres hematologa Srbije, Beograd 2024.   (M64)

  
  

  19. Ivan Petković, Marija Elez, Aleksandar Popović, Ana Stojković, Dane Krtinić. Polatuzumab-Vedotin+Bendamustin+Rituximab in relaps/ refractory diffuse large B-cell lymphoma (R/R DLBCL): single institution experience. Srpski Medicinski Časopis Lekarske Komore 2024; 5 (suppl 3):56.   6. Kongres hematologa Srbije, Beograd 2024.   (M64)

  
  

  20. Ivan Petković, Aleksandar Popović, Slavica Stojnev, Ana Stojković, Irena Conić. Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) – a rare entity. Srpski Medicinski Časopis Lekarske Komore 2024; 5 (suppl 3):66.   6. Kongres hematologa Srbije, Beograd 2024.    (M64)

  
  

  21. Ivan Petković, Marija Elez, Aleksandar Popović, Slavica Stojnev, Ana Stojković, Irena Conić. Primary CNS lymphoma (PCNSL) treated with MATRIX regimen with high-dose consolidation in first remission-case presentation. Srpski Medicinski Časopis Lekarske Komore 2024; 5 (suppl 3):54.   6. Kongres hematologa Srbije, Beograd 2024.  (M64)

  
  

  22. Ivan Petković. Izazovi tretmana relaps/refraktarnog difuznog B krupnoćelijskog limfoma u eri novih terapijskih modaliteta. Abstract book pp 35-6. Treći Nacionalni Simpozijum dnevne bolnice za hemioterapiju Vranje 2024.   (M62)

  
  

  23. Slavica Stojnev, Miljan Krstić, Ana Ristić Petrović, Irena Conić, Ivan Petković. Bland faces of aggressive intestinal lymphomas – report of two cases. [Meeting Abstract]. Arch Oncol 2024; 30 (Suppl 1): 6–7.  (M64)

  
  

  24. Dane Krtinić, Dragana Stokanović, Gorana Nedin Ranković, Ivan Petković, Ana Cvetanović, Irena Conić, Aleksandar Stojanov, Hristina Jovanović, Hristina Trajković, Milan Čevrljaković. Značaj transdermalnih formulacija opioidnih analgetika u farmakoterapiji bola. Abstract Book pp 26. Nedelja bolničke kliničke farmakologije 2023.online (M64)

  
  

  25. Ivan Petković, Aleksandar Popović, Mirjana Balić. Polatuzumab-Vedotin+Bendamustin+Rituksimab kao “most” ka autolognoj transplantaciji – prikaz slučaja. Abstract Book pp, xx-xx.  60. Kancerološka nedelja, Beograd 2023.  (M64)

  
  

  26. Ivan Petković, Aleksandar Popović, Marija Jevtić, Milan Čevrljaković.  Polatuzumab-Vedotin+Bendamustin+Rituximab u relaps/refraktarnom difuznom B krupnoćelijskom limfomu (R/R DBKL) – studija serije slučaja jednog centra. Abstract Book pp, xx-xx.  60. Kancerološka nedelja, Beograd 2023.  (M64)

  
  

  27. Milan Čevrljaković, Ivan Petković, Miljana Džunić, Aleksandar Popović, Mirjana Balić, Ana Cvetanović. Imunski posredovani hepatitis izazvan primenom pembrolizumaba kod pacijenta sa rekurentnim karcinomom glave i vrata. Abstract Book pp, xx-xx.  60. Kancerološka nedelja, Beograd 2023.  (M64)

  
  

  28. Aleksandar Popović, Ivan Petković, Mirjana Balić, Mirjana Todorović Mitić, Milan Čevrljaković, Dimitrije Đurđević, Ana Cvetanović. Autoimuni gastritis kod pacijenta sa melanomom lečenog adjuvantnim pembrolizumabom: prikaz slučaja. Abstract Book pp, xx-xx.  60. Kancerološka nedelja, Beograd 2023.   (M64)

  
  

  29. Aleksandar Popović, Ivan Petković, Mirjana Balić, Mirjana Todorović Mitić, Milan Čevrljaković, Filip Marković, Ana Cvetanović. Neželjeni efekat imunoterapije kao prediktor boljeg terapijskog odgovora- iskustvo centra. Abstract Book pp, xx-xx.  60. Kancerološka nedelja, Beograd 2023.  (M64)

  
  

  30.Tatjana Petković, Ivan Petković. Specifičnosti zdravstvene nege pacijenata sa metastatskim melanomom lečenih imunoterapijom. Abstract Book pp, xx-xx.  60. Kancerološka nedelja, Beograd 2023.  (M64) 

  
  

  31. Aleksandar Popović, Ivan Petković, Mirjana Todorović Mitić, Andrija Jović, Aleksandra Dimitrijević, Mirjana Balić.Primena nivolumaba kod pacijenata sa uznapredovalim melanomom-iskustvo klinike za onkologiju. Abstract book pp 46. Beogradski Dermatološki Dani  2023  (M64)

  
  

  32. Ivan Petković, Slavica Stojnev, Irena Conić, Milica Radić. Klinički aspekti limfoma gastrointestinalnog trakta. Abstract book pp 16-17.      Simpozijum SLD, Medicinski fakultet Niš 2023.  (M62)

  
  

  33. Slavica Stojnev, Miljan Krstić, Ivan Petković, Irena Conić, Ana Ristić Petrović. Patohistološki aspekti limfoma gastrointestinalnog trakta. Abstract book pp 14-15.      Simpozijum SLD, Medicinski fakultet Niš 2023. (M64)

  
  

  34. Milica Radić, Ivan Petković, Irena Conić, Ana Cvetanović, Katarina Branković. Uloga radioterapije u multidisciplinarnom tretmanu karcinoma dojke. Abstract book pp 8.      Simpozijum SLD, Medicinski fakultet Niš 2023. (M64)

  
  

  35. Irena Conić, Slavica Stojnev, Miljan Krstić, Ana Ristić Petrović, Ivan Petković. Savremene terapijske opcije u lečenju bolesnica sa uznapredovalim karcinomom grlića materice. Abstract book pp 12-13.      Simpozijum SLD, Medicinski fakultet Niš 2023. (M64)

  
  

  36. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Mirjana Todorović Mitić, Mirjana Balić, Andrija Jović, Irena Conić. Prikaz pacijenta sa vaginalnim melanomom i kompletnim odgovorom na nivolumab. Abstract Book pp, 170-1.  59. Kancerološka nedelja, Beograd 2022.  (M64)

  
  

  37. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Mirjana Todorović Mitić, Mirjana Balić, Andrija Jović.  Primena inhibitora kontrolnih tačaka kod pacijenata sa uznapredovalim melanomom-iskustvo Klinike za onkologiju UKC Niš. Abstract Book pp, 138-9.  59. Kancerološka nedelja, Beograd 2022.  (M64)

  
  

  38. Aleksandar Popović, Ivan Petković, Aleksandra Dimitrijević, Mirjana Todorović Mitić, Mirjana Balić, Andrija Jović, Andrija Rančić. Prikaz pacijenta sa anorektalnim mukozalnim melanomom i sistemskim lupusom lečenog nivolumabom. Abstract Book pp, 169-70.  59. Kancerološka nedelja, Beograd 2022.  (M64)

  
  

  39. Ivan Petković, Aleksandar Popović, Marija Jevtić. Polatuzumab Vedotin+Bendamustin+Rituximab in relapse/ refractory diffuse large B-cell lymphoma (R/R DLBCL) -single center case series study. Abstract book pp 50, 68.  5. Kongres hematologa Srbije, Novi Sad 2022.  (M64)

  
  

  40. Ivan Petković, Marija Jevtić, Aleksandar Popović. Ibrutinib in relapsed/ refractory mantle cell lymphoma (R/R MCL) patients– single center experience. Abstract book pp 51, 69.  5. Kongres hematologa Srbije, Novi Sad 2022.   (M64)

  
  

  41. Marija Jevtić,  Ivan Petković, Mladen Đorđević, Milica Stanković. Concomitant mycosis fungoides and retroperitoneal angiosarcoma- case report. Abstract book pp 44, 62.  5. Kongres hematologa Srbije, Novi Sad 2022.  (M64) 

  
  

  42. Ivan Petković. Savremeni koncepti terapije melanoma-od adjuvantne terapije do terapije metastatske bolesti. Abstract book pp 29-31. 2. Nacionalni Kongres Dnevne bolnice za hemioterapiju Vranje 2022  (M62)                                         

  
  

  43. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. Extranodal NK/T–Cell Lymphoma, Nasal Type Overlapping Aggressive NK–Cell Leukemia in Course of Progression, rare entity–case report. Abstract Book pp, 142-3.  58. Kancerološka nedelja, Beograd 2021.  (M64)

  
  

  44. Ivan Petković, Slavica Stojnev, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. EBV Negative Angioimmunoblastic T-Cell Lymphoma with Sequential Development of Diffuse Large B-Cell Lymphoma in Course of Progression. Abstract Book pp, 144-5.  58. Kancerološka nedelja, Beograd 2021. (M64)

  
  

  45. Miljana Džunić, Mirjana Stanić, Saša Dinić, Ivan Petković, Svetislav Vrbić, Miroslav Stojanović. Prognostički parametri kod pacijenata sa metastazama kolorektalnog karcinoma u jetri operisanih nakon konverzione biohemioterapije.   Abstract Book pp, 268-9.  56. Kancerološka nedelja,  Beograd 2019. (M64) 

  
  

  46. Ivan Petković, Emilija Vagaja, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. DA–EPOCH–R bez radioterapije vs. R–CHOP₂₁+radioterapija su bez signifikante razlike na ishod lečenja bolesnika sa primarnim medijastinalnim B krupnoćelijskim limfomom. Abstract book pp 008, 125. 4. Kongres hematologa Srbije, Niš 2019.  (M64)  

  
  

  47. Ivan Petković, Emilija Vagaja, Aleksandar Popović, Miljan Krstić, Ivica Pejčić. Rezidualna PET/CT pozitivnost ne korelira sa rezistencijom/ progresijom bolesti nakon DA–EPOCH–R indukcije kod primarnog medijastinalnog B krupnoćelijskog limfoma. Abstract book up 09, 100.  4. Kongres hematologa Srbije, Niš 2019.  (M64) usmeno izlaganje

  
  

  48. Tatjana Petković, Vesna Radojičić, Ivan Petković. Specifičnosti zdravstvene nege pacijenata sa metastatskim tumorima sa nepoznatim primarnim ishodištem.  Abstract Book op, 299-300. 55. Kancerološka nedelja, Beograd 2018.  (M64) 

  
  

  49. Ivan Petković, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić.  Prediktivni značaj Muris skora kod bolesnika sa difuznim B krupnoćelijskim limfomom tretiranih imunohemioterapijom. Abstract book op 19, 242-3.  Treći Kongres hematologa Srbije, Kragujevac 2015.  (M62) usmeno izlaganje

  
  

  50. Ivan Petković, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić. Značaj nivoa beta 2 mikroglobulina kod bolesnika sa difuznim krupnoćelijskim B limfomom u eri primene rituksimaba. Abstract book p 53, 312-3.  Treći Kongres hematologa Srbije, Kragujevac 2015.  (M64)

  
  

  51. Ivan Petković, Ivica Pejčić, Svetislav Vrbić, Mirjana Balić.  Muški pol je faktor rizika za smrtni ishod kod bolesnika sa difuznim B krupnoćelijskim limfomom. Abstract book p 52, 311-2. Treći Kongres hematologa Srbije, Kragujevac 2015.  (M64) 

  
  

  52. Ivan Petković. Uticaj starosti pacijenata na izbor tretmana kod novodijagnostikovanih difuznih B krupnoćelijskih limfoma. Abstract book pp 39, 218-22. Treći Kongres hematologa Srbije, Kragujevac 2015.  (M61) predavanje po pozivu

  
  

  53. Jelena Jeličić, Milena Todorović, Darko Antić, Jelena Bila, Boško Anđelić, Dragomir Stanisavljević, Vojin Vuković, Vladislava Đurašinović, Aleksandra Sretenović, Mihailo Smiljanić, Ivan Petković, Ivica Pejčić, Biljana Mihaljević. Prognostički značaj komorbiditeta kod bolesnika sa difuznim B krupnoćelijskim limfomom lečenih imunohemioterapijom. Abstract book op 21, 121. Treći Kongres hematologa Srbije, Kragujevac 2015.   (M64) 

  
  

  54. Miljan Krstić, Slavica Stojnev, Ivan Petković, Svetislav Vrbić, Ivica Pejčić. Ekspresija STAT3 u difuznom B-krupnoćelijskom limfomu nodalne i ekstranodalne lokalizacije. Abstract book p 55, 314-5. Treći Kongres hematologa Srbije, Kragujevac 2015.  (M64)

  
  

  55. Vrbić Svetislav, Pejčić Ivica, Simonović Nataša, Petković Ivan. Medikamentozna onkološka terapija medularnog tireoidnog karcinoma. Zbornik radova sa recenzijom, Medicinski fakultet Niš 2009: 86-90. (M63)